HomeCompareRPHCF vs SPHD

RPHCF vs SPHD: Dividend Comparison 2026

RPHCF yields 1.82% · SPHD yields 4.30%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RPHCF wins by $43.20M in total portfolio value· pulled ahead in Year 2
10 years
RPHCF
RPHCF
● Live price
1.82%
Share price
$15.20
Annual div
$0.28
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.23M
Annual income
$39,107,153.37
Full RPHCF calculator →
SPHD
SPHD
● Live price
4.30%
Share price
$49.61
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$567.37
Full SPHD calculator →

Portfolio growth — RPHCF vs SPHD

📍 RPHCF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRPHCFSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RPHCF + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RPHCF pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RPHCF
Annual income on $10K today (after 15% tax)
$154.90/yr
After 10yr DRIP, annual income (after tax)
$33,241,080.36/yr
SPHD
Annual income on $10K today (after 15% tax)
$365.92/yr
After 10yr DRIP, annual income (after tax)
$482.26/yr
At 15% tax rate, RPHCF beats the other by $33,240,598.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RPHCF + SPHD for your $10,000?

RPHCF: 50%SPHD: 50%
100% SPHD50/50100% RPHCF
Portfolio after 10yr
$21.63M
Annual income
$19,553,860.37/yr
Blended yield
90.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RPHCF right now

RPHCF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
4.2
Piotroski
5/9
SPHD
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RPHCF buys
0
SPHD buys
0
No recent congressional trades found for RPHCF or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRPHCFSPHD
Forward yield1.82%4.30%
Annual dividend / share$0.28$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%0%
Portfolio after 10y$43.23M$26.5K
Annual income after 10y$39,107,153.37$567.37
Total dividends collected$42.89M$5.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RPHCF vs SPHD ($10,000, DRIP)

YearRPHCF PortfolioRPHCF Income/yrSPHD PortfolioSPHD Income/yrGap
1$11,064$364.47$11,130$430.50$66.00SPHD
2← crossover$12,593$753.78$12,357$447.82+$236.00RPHCF
3$15,078$1,603.54$13,687$464.65+$1.4KRPHCF
4$19,722$3,588.75$15,126$480.98+$4.6KRPHCF
5$29,877$8,774.08$16,682$496.78+$13.2KRPHCF
6$56,812$24,844.41$18,362$512.03+$38.5KRPHCF
7$149,094$88,305.24$20,174$526.72+$128.9KRPHCF
8$592,694$433,162.94$22,127$540.84+$570.6KRPHCF
9$3,852,779$3,218,596.09$24,230$554.39+$3.83MRPHCF
10$43,229,627$39,107,153.37$26,493$567.37+$43.20MRPHCF

RPHCF vs SPHD: Complete Analysis 2026

RPHCFStock

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Full RPHCF Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this RPHCF vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RPHCF vs SCHDRPHCF vs JEPIRPHCF vs ORPHCF vs KORPHCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.